Mitochondrial medicine for aging and neurodegenerative diseases

P (Hemachandra) Reddy

    Research output: Contribution to journalArticle

    119 Citations (Scopus)

    Abstract

    Mitochondria are key cytoplasmic organelles, responsible for generating cellular energy, regulating intracellular calcium levels, altering the reduction-oxidation potential of cells, and regulating cell death. Increasing evidence suggests that mitochondria play a central role in aging and in neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Freidriech ataxia. Further, several lines of evidence suggest that mitochondrial dysfunction is an early event in most late-onset neurodegenerative diseases. Biochemical and animal model studies of inherited neurodegenerative diseases have revealed that mutant proteins of these diseases are associated with mitochondria. Mutant proteins are reported to block the transport of nuclear-encoded mitochondrial proteins to mitochondria, interact with mitochondrial proteins and disrupt the electron transport chain, induce free radicals, cause mitochondrial dysfunction, and, ultimately, damage neurons. This article discusses critical issues of mitochondria causing dysfunction in aging and neurodegenerative diseases, and discusses the potential of developing mitochondrial medicine, particularly mitochondrially targeted antioxidants, to treat aging and neurodegenerative diseases.

    Original languageEnglish (US)
    Pages (from-to)291-315
    Number of pages25
    JournalNeuroMolecular Medicine
    Volume10
    Issue number4
    DOIs
    StatePublished - Dec 2008

    Fingerprint

    Neurodegenerative Diseases
    Mitochondria
    Medicine
    Mitochondrial Proteins
    Mutant Proteins
    Cell Nucleus Active Transport
    Huntington Disease
    Amyotrophic Lateral Sclerosis
    Ataxia
    Electron Transport
    Organelles
    Free Radicals
    Parkinson Disease
    Alzheimer Disease
    Cell Death
    Animal Models
    Antioxidants
    Calcium
    Neurons

    Keywords

    • Adenosine triphosphate
    • Alzheimer's disease
    • Amyloid beta
    • Amyloid precursor protein
    • Amyotrophic lateral sclerosis
    • Caloric restricted
    • Electron transport chain
    • FRDA
    • Freidriech ataxia
    • Huntington's disease
    • Hydrogen peroxide
    • Mitochondrial DNA

    ASJC Scopus subject areas

    • Cellular and Molecular Neuroscience
    • Molecular Medicine
    • Neurology

    Cite this

    Mitochondrial medicine for aging and neurodegenerative diseases. / Reddy, P (Hemachandra).

    In: NeuroMolecular Medicine, Vol. 10, No. 4, 12.2008, p. 291-315.

    Research output: Contribution to journalArticle

    Reddy, P (Hemachandra). / Mitochondrial medicine for aging and neurodegenerative diseases. In: NeuroMolecular Medicine. 2008 ; Vol. 10, No. 4. pp. 291-315.
    @article{8995457f392d4c9ba7701ec9e78cd03d,
    title = "Mitochondrial medicine for aging and neurodegenerative diseases",
    abstract = "Mitochondria are key cytoplasmic organelles, responsible for generating cellular energy, regulating intracellular calcium levels, altering the reduction-oxidation potential of cells, and regulating cell death. Increasing evidence suggests that mitochondria play a central role in aging and in neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Freidriech ataxia. Further, several lines of evidence suggest that mitochondrial dysfunction is an early event in most late-onset neurodegenerative diseases. Biochemical and animal model studies of inherited neurodegenerative diseases have revealed that mutant proteins of these diseases are associated with mitochondria. Mutant proteins are reported to block the transport of nuclear-encoded mitochondrial proteins to mitochondria, interact with mitochondrial proteins and disrupt the electron transport chain, induce free radicals, cause mitochondrial dysfunction, and, ultimately, damage neurons. This article discusses critical issues of mitochondria causing dysfunction in aging and neurodegenerative diseases, and discusses the potential of developing mitochondrial medicine, particularly mitochondrially targeted antioxidants, to treat aging and neurodegenerative diseases.",
    keywords = "Adenosine triphosphate, Alzheimer's disease, Amyloid beta, Amyloid precursor protein, Amyotrophic lateral sclerosis, Caloric restricted, Electron transport chain, FRDA, Freidriech ataxia, Huntington's disease, Hydrogen peroxide, Mitochondrial DNA",
    author = "Reddy, {P (Hemachandra)}",
    year = "2008",
    month = "12",
    doi = "10.1007/s12017-008-8044-z",
    language = "English (US)",
    volume = "10",
    pages = "291--315",
    journal = "NeuroMolecular Medicine",
    issn = "1535-1084",
    publisher = "Humana Press",
    number = "4",

    }

    TY - JOUR

    T1 - Mitochondrial medicine for aging and neurodegenerative diseases

    AU - Reddy, P (Hemachandra)

    PY - 2008/12

    Y1 - 2008/12

    N2 - Mitochondria are key cytoplasmic organelles, responsible for generating cellular energy, regulating intracellular calcium levels, altering the reduction-oxidation potential of cells, and regulating cell death. Increasing evidence suggests that mitochondria play a central role in aging and in neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Freidriech ataxia. Further, several lines of evidence suggest that mitochondrial dysfunction is an early event in most late-onset neurodegenerative diseases. Biochemical and animal model studies of inherited neurodegenerative diseases have revealed that mutant proteins of these diseases are associated with mitochondria. Mutant proteins are reported to block the transport of nuclear-encoded mitochondrial proteins to mitochondria, interact with mitochondrial proteins and disrupt the electron transport chain, induce free radicals, cause mitochondrial dysfunction, and, ultimately, damage neurons. This article discusses critical issues of mitochondria causing dysfunction in aging and neurodegenerative diseases, and discusses the potential of developing mitochondrial medicine, particularly mitochondrially targeted antioxidants, to treat aging and neurodegenerative diseases.

    AB - Mitochondria are key cytoplasmic organelles, responsible for generating cellular energy, regulating intracellular calcium levels, altering the reduction-oxidation potential of cells, and regulating cell death. Increasing evidence suggests that mitochondria play a central role in aging and in neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Freidriech ataxia. Further, several lines of evidence suggest that mitochondrial dysfunction is an early event in most late-onset neurodegenerative diseases. Biochemical and animal model studies of inherited neurodegenerative diseases have revealed that mutant proteins of these diseases are associated with mitochondria. Mutant proteins are reported to block the transport of nuclear-encoded mitochondrial proteins to mitochondria, interact with mitochondrial proteins and disrupt the electron transport chain, induce free radicals, cause mitochondrial dysfunction, and, ultimately, damage neurons. This article discusses critical issues of mitochondria causing dysfunction in aging and neurodegenerative diseases, and discusses the potential of developing mitochondrial medicine, particularly mitochondrially targeted antioxidants, to treat aging and neurodegenerative diseases.

    KW - Adenosine triphosphate

    KW - Alzheimer's disease

    KW - Amyloid beta

    KW - Amyloid precursor protein

    KW - Amyotrophic lateral sclerosis

    KW - Caloric restricted

    KW - Electron transport chain

    KW - FRDA

    KW - Freidriech ataxia

    KW - Huntington's disease

    KW - Hydrogen peroxide

    KW - Mitochondrial DNA

    UR - http://www.scopus.com/inward/record.url?scp=60349108806&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=60349108806&partnerID=8YFLogxK

    U2 - 10.1007/s12017-008-8044-z

    DO - 10.1007/s12017-008-8044-z

    M3 - Article

    C2 - 18566920

    AN - SCOPUS:60349108806

    VL - 10

    SP - 291

    EP - 315

    JO - NeuroMolecular Medicine

    JF - NeuroMolecular Medicine

    SN - 1535-1084

    IS - 4

    ER -